"10.1371_journal.ppat.1004953","plos pathogens","2015-07-02T00:00:00Z","Emmanuel A Asante; Andrew Grimshaw; Michelle Smidak; Tatiana Jakubcova; Andrew Tomlinson; Asif Jeelani; Shyma Hamdan; Caroline Powell; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge","MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom","Conceived and designed the experiments: EAA JDFW JC. Performed the experiments: EAA AG MS TJ AT AJ SH CP SJ JML SB. Analyzed the data: EAA JDFW SB JC. Wrote the paper: EAA JDFW JC.","JC is a Director and JC and JDFW are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen owns the ICSM 18 and ICSM 35 antibodies used in this study. This does not alter our adherence to all PLOS policies on sharing data and materials.","2015","07","Emmanuel A Asante","EAA",13,TRUE,3,11,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
